A short circulating peptide nanofiber as a carrier for tumoral delivery
- 1 May 2013
- journal article
- Published by Elsevier BV in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 9 (4), 449-457
- https://doi.org/10.1016/j.nano.2012.10.009
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Preclinical and clinical studies of NK012, an SN-38-incorporating polymeric micelles, which is designed based on EPR effectAdvanced Drug Delivery Reviews, 2011
- A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumoursBritish Journal of Cancer, 2011
- Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivoProceedings of the National Academy of Sciences of the United States of America, 2011
- Delivering nanomedicine to solid tumorsNature Reviews Clinical Oncology, 2010
- Preclinical and clinical studies of anticancer agent‐incorporating polymer micellesCancer Science, 2009
- Factors Affecting the Clearance and Biodistribution of Polymeric NanoparticlesMolecular Pharmaceutics, 2008
- Renal clearance of quantum dotsNature Biotechnology, 2007
- Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast CancerJournal of Clinical Oncology, 2005
- Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicinBritish Journal of Cancer, 2004
- Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.Journal of Clinical Oncology, 1998